Shousen Hu
No.1 Jianshe Road
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
PSMC2 drives tumor progression in nasopharyngeal carcinoma by inhibiting ferroptosis through STAT3.
Journal: Discover oncology
Published: October 31, 2025
THBS1 upregulation by KLF7 in hypopharyngeal squamous cell carcinoma contributes to lung metastasis through the p38 MAPK signaling.
Journal: iScience
Published: July 30, 2025
The roles of IDH2 and glutathione metabolism in cetuximab resistance in head and neck squamous cell carcinoma investigated by metabolomics and transcriptomics.
Journal: Cellular signalling
Published: October 25, 2024
Deciphering the cellular landscape and potential targets of nasopharyngeal and oral cancers using single-cell RNA sequencing.
Journal: Cell biology international
Published: February 08, 2024
PSMC2 knockdown exerts an anti-tumor role in nasopharyngeal carcinoma through regulating AKT signaling pathway.
Journal: Cell cycle (Georgetown, Tex.)
Published: December 20, 2023
Suppression of N-Glycosylation of Zinc Finger Protein 471 Affects Proliferation, Invasion, and Docetaxel Sensitivity of Tongue Squamous Cell Carcinoma via Regulation of c-Myc.
Journal: The American journal of pathology
Published: August 31, 2023
Lipid metabolism as a target for cancer drug resistance: progress and prospects.
Journal: Frontiers in pharmacology
Published: August 08, 2023
Clinical diagnostic value of amino acids in laryngeal squamous cell carcinomas.
Journal: PeerJ
Published: January 20, 2023
Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Journal: Disease markers
Published: May 19, 2022
Analysis of lncRNA, miRNA and mRNA-associated ceRNA networks and identification of potential drug targets for drug-resistant non-small cell lung cancer.
Journal: Journal of Cancer
Published: September 27, 2019
Insulinoma-associated protein 1 controls nasopharyngeal carcinoma to radiotherapy by modulating cyclin D1-dependent DNA repair machinery.
Journal: Carcinogenesis
Published: April 17, 2019
Last Updated: 09/26/2026